MXPA02010868A - Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera. - Google Patents

Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera.

Info

Publication number
MXPA02010868A
MXPA02010868A MXPA02010868A MXPA02010868A MXPA02010868A MX PA02010868 A MXPA02010868 A MX PA02010868A MX PA02010868 A MXPA02010868 A MX PA02010868A MX PA02010868 A MXPA02010868 A MX PA02010868A MX PA02010868 A MXPA02010868 A MX PA02010868A
Authority
MX
Mexico
Prior art keywords
increasing
ovulation rate
nucleotide sequences
mammals
gene
Prior art date
Application number
MXPA02010868A
Other languages
English (en)
Spanish (es)
Inventor
Kenneth Pattrick Mcnatty
Original Assignee
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd filed Critical Agres Ltd
Publication of MXPA02010868A publication Critical patent/MXPA02010868A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA02010868A 2000-05-05 2001-05-04 Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera. MXPA02010868A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ500844A NZ500844A (en) 2000-05-05 2000-05-05 Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate
PCT/NZ2001/000073 WO2001085926A2 (en) 2000-05-05 2001-05-04 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate

Publications (1)

Publication Number Publication Date
MXPA02010868A true MXPA02010868A (es) 2004-09-06

Family

ID=19927611

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010868A MXPA02010868A (es) 2000-05-05 2001-05-04 Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera.

Country Status (15)

Country Link
US (1) US20040092007A1 (enExample)
EP (1) EP1292674B1 (enExample)
JP (1) JP2003532414A (enExample)
CN (1) CN1436237A (enExample)
AR (1) AR028411A1 (enExample)
AT (1) ATE401403T1 (enExample)
AU (2) AU2001260821B2 (enExample)
BR (1) BR0110616A (enExample)
CA (1) CA2408051A1 (enExample)
DE (1) DE60134852D1 (enExample)
MX (1) MXPA02010868A (enExample)
NZ (1) NZ500844A (enExample)
RU (1) RU2283866C2 (enExample)
WO (1) WO2001085926A2 (enExample)
ZA (1) ZA200208963B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
AU2005310357A1 (en) * 2004-12-02 2006-06-08 Agresearch Limited Modulation of ovulation
WO2007031590A1 (es) * 2005-09-13 2007-03-22 Neocodex, S.L. Método de detección in vitro de la predisposición a desarrollar alteraciones en la función ovárica
ES2338960B1 (es) * 2007-11-23 2011-04-19 Carnes Oviaragon S.C.L. Procedimiento de mejora de la productividad en ganado ovino.
CN105210981B (zh) * 2015-09-15 2018-09-28 中国科学院生物物理研究所 建立可应用于人类疾病研究的雪貂模型的方法及其应用
CN105941325A (zh) * 2016-06-17 2016-09-21 安徽省农业科学院畜牧兽医研究所 小尾寒羊母羊与澳洲白公羊杂交生产澳寒杂交母羊的方法
CN106614366A (zh) * 2016-12-29 2017-05-10 李振民 一种无抗生猪养殖方法
CN108753835A (zh) * 2018-05-30 2018-11-06 中山大学 一种利用CRISPR/Cas9编辑猪BMP15基因的方法
CN111440879A (zh) * 2020-04-27 2020-07-24 内蒙古大学 一种利用gdf9基因提高蒙古羊繁殖力的方法
CN111500744A (zh) * 2020-04-27 2020-08-07 内蒙古大学 一种基于gdf9基因编码区突变的蒙古羊繁殖力提高方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions

Also Published As

Publication number Publication date
BR0110616A (pt) 2004-04-06
JP2003532414A (ja) 2003-11-05
EP1292674A2 (en) 2003-03-19
AU6082101A (en) 2001-11-20
WO2001085926A3 (en) 2002-08-08
ZA200208963B (en) 2004-07-26
US20040092007A1 (en) 2004-05-13
AR028411A1 (es) 2003-05-07
ATE401403T1 (de) 2008-08-15
RU2283866C2 (ru) 2006-09-20
DE60134852D1 (de) 2008-08-28
WO2001085926A2 (en) 2001-11-15
EP1292674B1 (en) 2008-07-16
NZ500844A (en) 2003-06-30
CA2408051A1 (en) 2001-11-15
CN1436237A (zh) 2003-08-13
AU2001260821B2 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
Haines et al. Allele-specific non-CpG methylation of the Nf1 gene during early mouse development
US12227758B2 (en) Somatic haploid human cell line
Imamura et al. Dynamic CpG and non-CpG methylation of the Peg1/Mest gene in the mouse oocyte and preimplantation embryo
Wallace et al. The enigma of endonuclease VIII
AU772812C (en) Alzheimer's disease secretase
AU6672601A (en) Cold sensitive mutant dna polymerases
JPH1189588A5 (enExample)
ATE356866T1 (de) Polymerasenchimären
IN2014DN02483A (enExample)
HUP0002578A2 (hu) Hímszövet-specifikus szabályzó régió és alkalmazására szolgáló eljárás
CA2079454A1 (en) Steroid 5.alpha.-reductases
MXPA03002572A (es) Secuencias de nucleotidos que intervienen en la fertilidad de los machos y metodo de su uso.
AU2001237425A1 (en) Rna polymerase mutants with increased thermostability
WO2000047750A3 (en) Metalloproteases of the neprilysin family
WO2001085926A3 (en) Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
AU4985201A (en) Human gene critical to fertility
Klugbauer et al. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
AU2002257284A1 (en) Pna probes, probe sets, methods and kits pertaining to the detection of candida
ATE373095T1 (de) Mutierte muskelspezifische enhancer
Ito et al. Site-selective scission of human genome by artificial restriction DNA cutter
PT1322753E (pt) Novas redutases do acido 2,5-diceto-l-gluconico e metodos de utilizacao
TR199901606T2 (xx) DNA' n�n bir ak�� santrif�j�nde temizlenmesi.
FAN et al. Identification of a mutation hotspot in exon 8 of Wilson disease gene by cycle sequencing
Takama et al. Mutation analysis of the hMTH1 gene in sporadic human ovarian cancer.